Treatment of OSAHS with the mandibular advancement devices / 实用口腔医学杂志

ABSTRACT

The obstructive sleep apnoea/hypopnoea syndrome (OSAHS) affects approximately 2%-4% of the middle-aged population. It is characterized by obstruction of the upper airway during sleep, resulting in repetitive breathing pauses accompanied by oxygen desaturation. It has been recognized as an independent risk factor for disorders such as hypertension, cardiovascular diseases and sleepiness-related accidents. Treatment modalities for OSAHS at the present time include nasal continuous positive airway pressure( CPAP) , surgery option and oral appliances. However many patients refuse or cannot tolerate CPAP and surgery treatment and randomized trials report patient preference for o-ral appliances. Today, the most commonly used oral appliances are the mandibular advancement devices (MADs). This article provides an overview of OSAHS its epidemiology, clinical features, diagnosis and clinical application on treatment of OSAHS with MADs.